Characterization of intestinal O-glycome in reactive oxygen species deficiency
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0297292 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Radka Saldova und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Bioprocessing, NIBRT GlycoScience Group, Research and Training, Blackrock, Dublin, Ireland. Hauptthemen laut MEDLINE: Mucins, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation Ireland.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is characterized by chronic intestinal inflammation resulting from an inappropriate inflammatory response to intestinal microbes in a genetically susceptible host. Reactive oxygen species (ROS) generated by NADPH oxidases (NOX) provide antimicrobial defense, redox signaling and gut barrier maintenance. NADPH oxidase mutations have been identified in IBD patients, and mucus layer disruption, a critical aspect in IBD pathogenesis, was connected to NOX inactivation. To gain insight into ROS-dependent modification of epithelial glycosylation the colonic and ileal mucin O -glycome of mice with genetic NOX inactivation ( Cyba mutant) was analyzed. O -glycans were released from purified murine mucins and analyzed by hydrophilic interaction ultra-performance liquid chromatography in combination with exoglycosidase digestion and mass spectrometry. We identified five novel glycans in ileum and found minor changes in O -glycans in the colon and ileum of Cyba mutant mice. Changes included an increase in glycans with terminal HexNAc and in core 2 glycans with Fuc-Gal- on C3 branch, and a decrease in core 3 glycans in the colon, while the ileum showed increased sialylation and a decrease in sulfated glycans. Our data suggest that NADPH oxidase activity alters the intestinal mucin O -glycans that may contribute to intestinal dysbiosis and chronic inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Institute for Bioprocessing, NIBRT GlycoScience Group, Research and Training, Blackrock, Dublin, Ireland.
- CÚRAM, SFI Research Centre for Medical Devices, National University of Ireland, Galway, Ireland.
- School of Medicine, University College Dublin, Dublin, Ireland.
- Proteomics Core Facility, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Faculty of Health Science, Department of Life Science and Health, Oslo Metropolitan University, Oslo, Norway.
ORCID-Profile: Radka Saldova
Förderung
- Science Foundation Ireland
Zitieren
APA
Saldova, R., Thomsson, K. A., Wilkinson, H., Chatterjee, M., Singh, A. K., Karlsson, N. G., & Knaus, U. G. (2024). Characterization of intestinal O-glycome in reactive oxygen species deficiency. PLOS ONE. https://doi.org/10.1371/journal.pone.0297292
Vancouver
Saldova R, Thomsson KA, Wilkinson H, Chatterjee M, Singh AK, Karlsson NG, et al. Characterization of intestinal O-glycome in reactive oxygen species deficiency. PLOS ONE. 2024. doi:10.1371/journal.pone.0297292
BibTeX
@article{Saldova2024,
author = {Saldova, Radka and Thomsson, Kristina A and Wilkinson, Hayden and Chatterjee, Maitrayee and Singh, Ashish K and Karlsson, Niclas G and Knaus, Ulla G},
title = {Characterization of intestinal O-glycome in reactive oxygen species deficiency},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0297292}
}
EUVIMED